A single center experience for clinical evaluation of paroxysmal cold hemoglobinuria and Donath‐Landsteiner testing

• Published in: Transfusion (Philadelphia, Pa.) Vol. 63; no. 10; pp. 1969 - 1977
• Main Authors: Villar‐Prados, Alejandro, Abdelmonem, Mohamed, Duda, Molly, Chien, May, Yunce, Muharrem
• Format: Journal Article
• Language: English
• Published: Bethesda Wiley Subscription Services, Inc 01-10-2023
• Subjects: Anemia; Antibodies; Autoimmune hemolytic anemia; Availability; Hemolytic anemia; L-Lactate dehydrogenase; Lactate dehydrogenase; Paroxysmal cold hemoglobinuria; Reticulocytes; Statistical analysis; Steroid hormones
• ISSN: 0041-1132; 1537-2995
• DOI: 10.1111/trf.17520

Abstract
Background
Paroxysmal cold hemoglobinuria (PCH) is a rare form of autoimmune hemolytic anemia (AIHA), mainly affecting children. The diagnosis and management are challenging due to similarities to other causes for AIHA and limited availability to Donath‐Landsteiner (DL) testing.
Study Design and Methods
In this single‐center retrospective study, we aimed to characterize the clinical presentation and outcomes of PCH patients, defined as having positive Donath‐Landsteiner antibodies, compared to a cohort of AIHA patients.
Results
DL‐positive patients were observed to have higher lactate dehydrogenase levels and lower reticulocyte counts compared to DL‐negative patients, although this was not statistically significant. We also observed that using steroids in DL‐positive patients did not significantly impact their recovery.
Discussion
Our findings support the limited published data on PCH patients and further prompt larger multicenter studies to further characterize these patients so that they are more readily identified, especially in centers where DL antibody testing is not readily available.